Brief: Medical Developments International Says U.S. FDA Lifted Agency's Clinical Hold On Penthrox
02/03/2022 24:55
March 2 (Reuters) - Medical Developments International Ltd
MVP.AX :
* MEDICAL DEVELOPMENTS INTERNATIONAL LTD - U.S. FDA HAS
UNCONDITIONALLY LIFTED AGENCY'S CLINICAL HOLD ON PENTHROX
* MEDICAL DEVELOPMENTS INTERNATIONAL LTD - MVP CAN
IMMEDIATELY
BEGIN PREPARING FOR ITS PHASE III US CLINICAL TRIAL
Source text for Eikon: ID:nASX7LzcHn
Further company coverage: MVP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medical Developments International
See all newsBrief: Medical Developments International Reports Group Revenue For Q1 FY27 Of A$10.2 Million
Brief: Medical Developments International Says CEO Brent MacGregor Intends To Step Down
Australia's Medical Developments International gains on higher annual revenue
Brief: Medical Developments International Logs FY Full Revenue A$42.6 Million
Medical Developments International soars on robust quarterly revenue